@article{3c7cbf3ba85a470493dd40320cf47d3d,
title = "Development of an HIV reporter virus that identifies latently infected CD4+ T cells",
abstract = "There is no cure for HIV infection, as the virus establishes a latent reservoir, which escapes highly active antiretroviral treatments. One major obstacle is the difficulty identifying cells that harbor latent proviruses. We devised a single-round viral vector that carries a series of versatile reporter molecules that are expressed in an LTR-dependent or LTR-independent manner and make it possible to accurately distinguish productive from latent infection. Using primary human CD4+ T cells, we show that transcriptionally silent proviruses are found in more than 50% of infected cells. The latently infected cells harbor proviruses but lack evidence for multiple spliced transcripts. LTR-silent integrations occurred to variable degrees in all CD4+ T subsets examined, with CD4+ TEM and CD4+ TREG displaying the highest frequency of latent infections. This viral vector permits the interrogation of HIV latency at single-cell resolution, revealing mechanisms of latency establishment and allowing the characterization of effective latency-reversing agents.",
keywords = "CD4 T cell subsets, CD4+ T memory cells, CD4+ T stem cells, HIV integration, HIV persistence, HIV reservoir, HIV-1, latency establishment, mass cytometry, reporter virus",
author = "Kim, {Eun Hye} and Lara Manganaro and Michael Schotsaert and Brown, {Brian D.} and Mulder, {Lubbertus C.F.} and Viviana Simon",
note = "Funding Information: We thank Dr. Adeeb Rahman and his team at the Human Immune Monitoring Core of Icahn School of Medicine at Mount Sinai for expertise and assistance with the CyTOF experiments. The following reagents were obtained through the National Institutes of Health (NIH) HIV Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID): J-Lat Full Length Cells (6.3), ARP-9846, contributed by Dr. Eric Verdin, and raltegravir (Isentress; MK-0518), ARP-11680, contributed by Merck & Company, Inc. The graphical abstract and Figures 2 A and 3 A were created using BioRender.com . This research was supported in part by NIH / NIAID grant R01AI136916 (V.S.) and NIH grant AI150355 (L.C.F.M). Funding Information: We thank Dr. Adeeb Rahman and his team at the Human Immune Monitoring Core of Icahn School of Medicine at Mount Sinai for expertise and assistance with the CyTOF experiments. The following reagents were obtained through the National Institutes of Health (NIH) HIV Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID): J-Lat Full Length Cells (6.3), ARP-9846, contributed by Dr. Eric Verdin, and raltegravir (Isentress; MK-0518), ARP-11680, contributed by Merck & Company, Inc. The graphical abstract and Figures 2A and 3A were created using BioRender.com. This research was supported in part by NIH/NIAID grant R01AI136916 (V.S.) and NIH grant AI150355 (L.C.F.M). E.H.K. and V.S. designed the research. E.H.K. performed the experiments. L.C.F.M. designed the proviral vectors. E.H.K. performed and analyzed data. E.H.K. generated figures with the input of L.C.F.M. L.M. and V.S. E.H.K. L.C.F.M. and V.S. interpreted the data. B.D.B. provided critical reagents. M.S. and L.M. provided critical insight for flow data analysis and interpretation. E.H.K. drafted the manuscript. E.H.K. L.C.F.M. L.M. and V.S. revised the final manuscript. All authors approved the final version. The authors declare no competing interests. Publisher Copyright: {\textcopyright} 2022 The Authors",
year = "2022",
month = jun,
day = "20",
doi = "10.1016/j.crmeth.2022.100238",
language = "English",
volume = "2",
journal = "Cell Reports Methods",
issn = "2667-2375",
publisher = "Cell Press",
number = "6",
}